Blood Cancer

Donor Search and Match

For a blood stem cell transplant to be successful, the HLA (tissue characteristics) of the donor need to match as closely as possible to the patient. A donor may be related to a patient or might be a complete stranger that is listed on any blood stem cell donor registry anywhere in the world.

The search for a matching donor

If someone is diagnosed with blood cancer or a blood disorder and the doctors decide that a blood stem cell transplant is their best chance of survival, then they will begin the search for a matching donor.

The first step is to check whether any of the patient’s siblings would be a suitable donor. Only approximately 30% of patients find a matching donor within their family. If there are not matching siblings, then a search for an unrelated donor is necessary by checking blood stem cell onor registries around the world.

A matching donor needs to be someone whose relevant HLA characteristics (tissue characteristics) are ideally a 100 percent match with the patient – and that donor could be you!

What makes a perfect match

HLA characteristics are the most important factor in finding a matching donor. In order for a stem cell transplant to have the highest chance of success, ideally 10 out of 10 relevant HLA characteristics should match between the patient and the donor. If a patient is lucky enough to have several matches, other factors will be analysed to find the best match. This is why we test more than 10 HLA characteristics.

As part of the initial typing, we also tissue type for further parameters that could prove advantageous, either now or in the future, such as the entire KIR receptor family, MICA/B, CCR5, HLA-DPB1, HLA-E, HLA-DQA1, HLA-DPA1, HLA-DRB3/4/5 and the ABO and Rh blood groups. In addition, our donors are also tested for cytomegalovirus (CMV), a common herpes virus.

Popular articles
Help us to register even more lifesavers
We’d love it if you could help us to get more people on the registry and thus give new hope for life to many blood cancer patients.